20-19975070-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_018993.4(RIN2):​c.1045C>T​(p.Pro349Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,613,520 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P349L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00096 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 3 hom. )

Consequence

RIN2
NM_018993.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 3.06

Publications

6 publications found
Variant links:
Genes affected
RIN2 (HGNC:18750): (Ras and Rab interactor 2) The RAB5 protein is a small GTPase involved in membrane trafficking in the early endocytic pathway. The protein encoded by this gene binds the GTP-bound form of the RAB5 protein preferentially over the GDP-bound form, and functions as a guanine nucleotide exchange factor for RAB5. The encoded protein is found primarily as a tetramer in the cytoplasm and does not bind other members of the RAB family. Mutations in this gene cause macrocephaly alopecia cutis laxa and scoliosis (MACS) syndrome, an elastic tissue disorder, as well as the related connective tissue disorder, RIN2 syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2011]
RIN2 Gene-Disease associations (from GenCC):
  • RIN2 syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007055372).
BP6
Variant 20-19975070-C-T is Benign according to our data. Variant chr20-19975070-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 436540.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000959 (146/152288) while in subpopulation AMR AF = 0.00229 (35/15294). AF 95% confidence interval is 0.00169. There are 0 homozygotes in GnomAd4. There are 74 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018993.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RIN2
NM_018993.4
MANE Select
c.1045C>Tp.Pro349Ser
missense
Exon 9 of 13NP_061866.1Q8WYP3-1
RIN2
NM_001242581.2
c.1192C>Tp.Pro398Ser
missense
Exon 8 of 12NP_001229510.1Q8WYP3-2
RIN2
NM_001378238.1
c.427C>Tp.Pro143Ser
missense
Exon 8 of 12NP_001365167.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RIN2
ENST00000255006.12
TSL:2 MANE Select
c.1045C>Tp.Pro349Ser
missense
Exon 9 of 13ENSP00000255006.7Q8WYP3-1
RIN2
ENST00000440354.2
TSL:1
c.463+14259C>T
intron
N/AENSP00000391239.2E7EPJ1
RIN2
ENST00000484638.1
TSL:1
n.889C>T
non_coding_transcript_exon
Exon 5 of 9

Frequencies

GnomAD3 genomes
AF:
0.000959
AC:
146
AN:
152174
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00146
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000925
AC:
228
AN:
246564
AF XY:
0.000909
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00258
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000932
Gnomad NFE exome
AF:
0.00115
Gnomad OTH exome
AF:
0.00134
GnomAD4 exome
AF:
0.00113
AC:
1653
AN:
1461232
Hom.:
3
Cov.:
37
AF XY:
0.00110
AC XY:
803
AN XY:
726866
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33480
American (AMR)
AF:
0.00273
AC:
122
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.000132
AC:
7
AN:
52932
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00130
AC:
1442
AN:
1111866
Other (OTH)
AF:
0.00128
AC:
77
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
93
185
278
370
463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000959
AC:
146
AN:
152288
Hom.:
0
Cov.:
32
AF XY:
0.000994
AC XY:
74
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41582
American (AMR)
AF:
0.00229
AC:
35
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5142
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00146
AC:
99
AN:
68022
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
7
14
22
29
36
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00118
Hom.:
1
Bravo
AF:
0.00117
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00132
AC:
11
ExAC
AF:
0.000885
AC:
107
EpiCase
AF:
0.00104
EpiControl
AF:
0.00154

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
1
-
Inborn genetic diseases (1)
-
1
-
not specified (1)
-
-
1
RIN2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
19
DANN
Benign
0.92
DEOGEN2
Benign
0.034
T
Eigen
Benign
-0.11
Eigen_PC
Benign
0.0084
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.0071
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.69
N
PhyloP100
3.1
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.11
Sift
Benign
0.46
T
Sift4G
Benign
0.97
T
Polyphen
0.11
B
Vest4
0.20
MVP
0.29
MPC
0.47
ClinPred
0.038
T
GERP RS
5.4
Varity_R
0.080
gMVP
0.20
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201486809; hg19: chr20-19955714; COSMIC: COSV99656925; COSMIC: COSV99656925; API